Rowling's Harry Potter book series was adapted into eight fantasy films, starting with Harry Potter and the Philosopher's Stone (2001) and concluding with Harry Potter and the Deathly Hallows – Part 2 ...

Indulgent dishes enticing us with fat and sugar can feel impossible to avoid, especially during the holidays. Experts confirm it’s more than a feeling: Half a century of food trends has created ...

Your cells remember being obese — and actively try to return to that state, a study says Cara Lynn Shultz is a writer-reporter at PEOPLE. Her work has previously appeared in Billboard and Reader ...

Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental Celebrity trainer and best-selling author Jorge Cruise isn’t shy when it comes to talking belly fat — and how he, 40 ...

Ferozan has over 20 years of experience writing and editing in the health and wellness sphere. She has worked as a ...

Fat Joe blasted the Foundational Black Americans (FBA) group as “radical Black racists,” during a recent interview. The Bronx-bred rapper of Cuban/ Puerto Rican descent sparked debate after ...

Subcutaneous fat is the fat right under your skin—the kind you can pinch. It keeps you warm and stores energy. Your muscles are beneath, and organs like the liver, kidneys, and intestines (colon ...

In a first, scientists at the World Health Organisation (WHO) have endorsed a new class of medicines known as GLP-1 receptor agonists, which mimic a hormone that regulates appetite and blood sugar ...

In a study, people who took Zepbound had fewer breathing interruptions. The FDA has expanded the approval of Eli Lilly’s obesity medication Zepbound to include treating moderate to severe ...

The number of people classed as obese in the US has dipped for the first time in more than a decade, giving experts some hope of seeing a reversal in concerning health trends. Researchers from the ...

A new type of obesity drug being developed by Novo Nordisk has fallen short of expectations set by the company in a closely watched Phase 3 trial, causing shares to lose nearly a fifth of their value ...

LONDON/COPENHAGEN, Dec 20 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab on Friday revealed disappointing results in a late-stage trial for its experimental next-generation obesity drug ...